We are live on ! Find out more
APVO icon

Aptevo Therapeutics

hedge funds and large institutions have $7.44M invested in Aptevo Therapeutics in 2019 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

43% less capital invested

Capital invested by funds: $13.1M → $7.44M (-$5.71M)

Holders
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$441K
Puts
Net Calls
+$441K
Net Calls Change
-$224K
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Stonepine Capital Management
Oregon
$2.01M
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$1.44M
Renaissance Technologies
3
Renaissance Technologies
New York
$1.27M
PWAM
4
Park West Asset Management
California
$588K
Vanguard Group
5
Vanguard Group
Pennsylvania
$512K
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$319K
WVP
7
Worth Venture Partners
New Jersey
$221K
BlackRock
8
BlackRock
New York
$180K
SC
9
Sessa Capital
New York
$106K
Geode Capital Management
10
Geode Capital Management
Massachusetts
$84K
UBS Group
11
UBS Group
Switzerland
$81K
WG
12
Winton Group
United Kingdom
$80K
Bank of New York Mellon
13
Bank of New York Mellon
New York
$59K
BCM
14
Bridgeway Capital Management
Texas
$55K
BFM
15
Boothbay Fund Management
New York
$46K
AG
16
Algert Global
California
$44K
ARTA
17
A.R.T. Advisors
New York
$41K
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$37K
QI
19
QS Investors
New York
$37K
CL
20
CSS LLC
Illinois
$36K
Northern Trust
21
Northern Trust
Illinois
$35K
ACA
22
Atlas Capital Advisors
Wyoming
$28.9K
HKAM
23
Horizon Kinetics Asset Management
New York
$22K
CSIC
24
Clifford Swan Investment Counsel
California
$16K
PAG
25
Private Advisor Group
New Jersey
$14K